Dr. Taine T.V. Pechet is a thoracic oncologist at Penn Medicine in Philadelphia. He holds the titles of Chief of Surgery at Penn Presbyterian Medical Center and Professor of Clinical Surgery, and in those roles treats patients with advanced lung and esophageal cancers as well as other thoracic cancers like malignant pleural mesothelioma. Dr. Pechet
Dr. Seth Blank is a thoracic surgeon who treats patients diagnosed with lung cancer, pleural mesothelioma, esophageal cancer, and other thoracic malignancies. He is a member of the active staff at Maine General Medical Center in Augusta, Maine, and previously practiced at Maine Thoracic Surgery in Falmouth, Maine. Dr. Blank is skilled in video-assisted thoracic
Dr. Igor Brichkov is a thoracic surgeon and oncologist at the Maimonides Medical Center in Brooklyn, New York. He is also the Director of Esophageal and Foregut Surgery. His areas of expertise are lung, esophageal, and thoracic cancers and thoracic surgery, and he is especially skilled in the use of minimally invasive surgical techniques for
A study published in Nature’s new open-access journal NPJ Precision Oncology reports that researchers tested the prognostic value of a clonal gene signature from malignant pleural mesothelioma tumor samples and found them to have high prognostic values and reproducibility. The results suggest that the information will help physicians treating patients with the rare form of cancer will
Dr. Sandeep J. Khandar is a cardiothoracic and thoracic surgeon and member of the Virginia Cancer Specialists Physicians Group which practices within the INOVA Health System in Northern Virginia. Board-certified in Cardiothoracic Thoracic and General Surgery, he has a special interest in the management of lung cancer, malignant pleural mesothelioma, and other thoracic malignancies using
Dr. Miguel Alvelo-Rivera is a thoracic surgical oncologist at Henry Ford Health in Detroit, Michigan. He specializes in the use of minimally invasive surgical procedures to treat patients with lung cancer, esophageal cancer, and other thoracic malignancies including malignant pleural mesothelioma. Dr. Alvelo-Rivera works as part of a multidisciplinary team that includes medical oncologists, pulmonologists,
Dr. John R. Roberts is a board-certified thoracic surgeon at Baptist Health’s Eugene M. & Christine E. Lynn Cancer Institute in Boca Raton, Florida. His clinical interests center on the use of minimally invasive and robotic surgical techniques for the treatment of patients diagnosed with lung cancer, esophageal cancer, and thoracic malignancies like pleural mesothelioma.
Dr. David S. Schrump is the Surgical Chief of the Thoracic Surgery Branch of the National Cancer Institute’s Center for Cancer Research. In this role, he oversees clinical and translational research about thoracic malignancies, particularly lung and esophageal cancers and malignant pleural mesotheliomas. Dr. Schrump pioneered the development of epigenomic therapies for thoracic cancers and
Dr. Evan S. K. Ong is a general surgeon and surgical oncologist at the Swedish Medical Center in Seattle, Washington. He specializes in the use of state-of-the-art surgical techniques, including minimally invasive and robotic surgery for hepatic and pancreatic tumors, hyperthermic intraperitoneal chemoperfusion (HIPEC) for peritoneal mesothelioma and other surface malignancies that have disseminated to
Dr. Mark Richard Dylewski is a thoracic surgeon at the Baptist Health South Florida and its affiliated Miami Cancer Institute in Miami, Florida. He holds the titles of Chairman of Thoracic Surgery and Director of Robotic Thoracic Surgery at Baptist Health South Florida and Chief of Thoracic Surgery at Miami Cancer Institute. Dr. Dylewski has